Introduction
Transcriptional regulation is known to be a complex process. The appropriate transcription from the promoter is speci®ed by the type of cis-acting DNA control elements contained in the promoter and their arrangement. It is also determined by the regulatory state of sequence-speci®c DNA-binding proteins (transacting factors) that recognize cis-acting DNA control elements. An additional level of complexity to transcription regulation is provided by the binding of distinct trans-acting factors to the same cis-acting element. Such proteins occur in subfamilies Fos and Jun (Zi, 1990) , cAMP response element binding/ activating transcription factor (CREB/ATF) (Hoeer et al., 1988; Gonzalez et al., 1989; Hai et al., 1989) , Oct (Clerc et al., 1988; Sturm et al., 1988; Scholer et al., 1989; Rosner et al., 1990) , MyoD (Weintraub et al., 1991) , and C/EBP (Williams et al., 1991) .
The proteins belonging to the dierent subfamilies of the same family are also known to bind to the same cis-acting element. The family of proteins which share a conserved basic domain, includes Fos, Jun, CREB, C/EBP and DBP. Three distinct proteins (C/EBPa, C/ EBPb and DBP) of this family can bind to the D site (7109 to 786) of the albumin promoter and transactivate transcription from this promoter (Descombes et al., 1990; Mueller et al., 1990) . The proteins of the C/EBP subfamily contain a basic DNA-binding region and a leucine zipper domain that is necessary for the formation of functionally active homo-and heterodimers. Comparison of the amino acid sequence of C/ EBPa and C/EBPb showed that they have an extraordinary similarity in the leucine zipper and its associated DNA-binding domains located in the Cterminal ends. However, the amino termini of the two proteins exhibit no notable similarity in primary amino acid sequence (Descombes et al., 1990) . The third protein, DBP, that binds to the D site of albumin promoter is only distantly related to C/EBPa and C/ EBPb (Mueller et al., 1990) . Only the basic region of DBP exhibits signi®cant sequence similarity with the analogous regions of C/EBPa and C/EBPb. In contrast to C/EBPa and C/EBPb, DBP does not contain a leucine zipper structure and exhibits relatively greater restriction in the binding speci®city (Mueller et al., 1990) . The developmental pattern of C/EBPa and C/ EBPb mRNAs indicate earlier accumulation of C/ EBPb relative to C/EBPa (Thomassin et al., 1992) . On the other hand, C/EBPa is expressed much earlier than DBP during liver development (Birkenmeier et al., 1989) . These data suggest that C/EBPa, C/EBPb and DBP might execute qualitatively distinct functions that are required at dierent stages of liver development (Mueller et al., 1990) .
Here, we report another example where distinct proteins, which apparently belong to the dierent subfamilies of related transcription factors, bind to the same cis-acting element. The metallothionein (MT) genes encode low-molecular weight cysteine-rich proteins that play a major role in the detoxi®cation of heavy metals. Deletion analysis of the mMT-I gene has revealed the cis-acting sequences necessary for its basal and inducible expression (Carter et al., 1984; Stuart et al., 1984; Datta and Jacob, 1993) One of the cis-acting elements involved in constitutive transcription of the mMT-I gene is the MRE-c' region (7135 to 7110) which is comprised of the metal regulatory element MRE-c' and parts of its 5' and 3'¯anking sequence. Deletion of the MRE-c' region resulted in a 6 ± 7-fold decrease in the mMT-I promoter activity (Datta and Jacob, 1993) . Previously, we have puri®ed and characterized a rat liver protein C'BP-1 (a dimer of the 34 kDa polypeptides) which binds to MRE-c' in a metal independent manner (Aniskovitch and Jacob, 1997). C'BP-1 could also bind to the region 7210 to 7175 of the mMT-I promoter. C'BP-1 stimulated transcription from the mMT-I promoter through binding to its cognate cis elements. In this study, we puri®ed and characterized a 28 kDa protein, C'BP-2, from a rat hepatoma, which recognizes sequences overlapping with the C'BP-1 binding sites on the mMT-I promoter and trans-activates transcription from the mMT-I promoter. Our data suggest that C'BP-1 is closely related to C/EBPd (Aniskovitch and Jacob, 1997), while C'BP-2 is closely related to CP2. The C'BP-1 binding activity was detected by EMSA utilizing a EDTA-containing buer system, as a major activity for MRE-c' in nonproliferating adult liver cells, but not in rat hepatoma cells. On the contrary, the C'BP-2 binding activity was detected as a dominant activity for MRE-c' in rat hepatoma cells but not in nonproliferating adult liver cells. C'BP-1 and C'BP-2 might, therefore, serve qualitatively distinct functions at dierent stages of growth and/or dierentiation of hepatocytes.
Results
Previously, we have puri®ed a rat liver protein, C'BP-1, that represents a dimer of a 34 kDa polypeptide and speci®cally interacts with the MRE-c' region (7135 to 7110) of the mMT-I gene in a metal independent manner (Aniskovitch and Jacob, 1997). The 34 kDa polypeptide was barely detectable in addition to polypeptides with M r 70 and 21.5 kDa when rat liver nuclear extract and the MRE-c' oligonucleotide as a probe were used for Southwestern analysis (Figure 1 , lanes 1 and 3). However, when rat hepatoma nuclear extract was used for Southwestern analysis, one additional polypeptide with M r 28 kDa was detected ( Figure 1, lanes 2 and 4) .
We then compared rat liver nuclear extract with rat hepatoma nuclear extract in electrophoretic mobility shift assay (EMSA) using 32 P-labeled MRE-c' as a probe (Figure 2 ). Complex A formed by C'BP-1 (Aniskovitch and Jacob, 1997) was observed as a major complex when rat liver nuclear extract was used. This complex was selectively competed out by the homologous competitor MRE-c' (lane 7) but not with Sp1 (lane 8) and poly(dI-dC) (lanes 9 and l0). However, when rat hepatoma nuclear extract was used in EMSA, a complex B with the faster mobility than complex A was observed as a dominant complex, which was speci®cally competed out by the MRE-c' oligonucleotide (lanes 1 ± 5). Complex B formed by the proteins of hepatoma nuclear extract and complex A formed by the proteins of rat liver nuclear extract could be detected only after prolonged exposure of the gel. The MRE-c' (C')-binding (B) protein (P) that formed complex B has been designated C'BP-2. To identify the speci®c protein involved in the formation of complex B, the MRE-c'-binding activity was puri®ed.
C'BP-1 and C'BP-2 each have distinct chromatographic behavior
We used a puri®cation protocol similar to that used for puri®cation of C'BP-1 from the rat liver to purify the C'BP-2 shifting activity. The puri®cation protocol included chromatographic fractionation on DEAESephadex A-25, heparin-Sepharose CL-6B, CM-Sepharose CL-6B and MRE-c' -Sepharose anity columns. The chromatographic behavior of C'BP-2 was compared with that of C'BP-1 (Table 1) . Most of the C'BP-2 activity¯owed through the DEAESephadex column, whereas the most of C'BP-1 was present in the 200 mM KCI fraction. C'BP-1 and C'BP-2 also exhibited distinct chromatographic behavior during fractionation on the heparin-Sepharose and MRE-c' -Sepharose anity columns. The C'BP-1 activity was present in the 400 mM KCl eluate of the heparin-Sepharose column whereas the C'BP-2 activity was recovered mainly in the 500 mM KCl eluate of the same column. The C'BP-1 activity eluted mainly in the 250 mM KCl fraction of the MRE-c'-Sepharose anity column whereas the C'BP-2 activity was present mainly in the 500 mM KCl fraction of the same column. Thus, C'BP-1 and C'BP-2 exhibit distinct chromatographic behavior on DEAE-Sephadex A-25, heparin-Sepharose CL-6B and MRE-c' -Sepharose anity columns. This suggests that C'BP-1 and C'BP-2 are distinct proteins.
C'BP-2 was puri®ed 3500-fold relative to nuclear extract ( Table 2) . Analysis of the sample from the second pass anity chromatography by SDS gel electrophoresis revealed that it consists predominantly of a 28 kDa polypeptide (Figure 3, lane 4) .
Identi®cation of C'BP-2 as a 28 kDa polypeptide
To determine unambiguously that the 28 kDa species is the active binding protein, several approaches were used. First, anity-puri®ed C'BP-2 was subjected to preparative SDS gel electrophoresis, the gel was divided into slices, and the protein in each slice was excised and eluted. SDS was removed from the protein by acetone precipitation, and the precipitated protein was resuspended in 6 M GnHCl to denature the polypeptide chains. Subsequent removal of GnHCl by dialysis allowed refolding of the polypeptide chains and recovery of DNA binding activities as determined by gel shift (Figure 4) . Only the slice which contained the 25 ± 30 kDa polypeptides exhibited the C'BP-2 activity ( Figure 4a , lane 4). The behavior of native C'BP-2 was identical to that of renatured 28 kDa polypeptide in the competition EMSA (Figure 4b) .
Second, sedimentation analysis of the C'BP-2 activity was performed to estimate the native molecular weight of C'BP-2. Anity-puri®ed C'BP-2 was sedimented through a glycerol gradient. Following centrifugation, a portion of each gradient fraction was assayed for the C'BP-2 binding activity. The C'BP-2 activity peaked at the same fraction of gradient as carbonic anhydrase (31 kDa protein) with a Svedberg coecient of 2.8 S ( Figure 5 ). C'BP-2, therefore, exists 1 2 3 4 5 6 7 8 9 10 B A Figure 2 Electrophoretic mobility shift assays using nuclear extract from Morris hepatoma 3924A and from the livers of rats bearing Morris hepatoma 3924A. The 32 P-labeled MRE-c' oligonucleotide was used as a probe. Nuclear extract (3 mg) from the hepatoma (lanes 1 ± 5) or from the livers of tumorbearing rats (lanes 6 ± 10) was preincubated with unlabeled competitor DNAs for 10 min prior to addition of 1 ng of the radiolabeled probe and 50 ng of poly(dI-dC). The reaction mixture was further incubated at room temperature for 30 min. The DNA-protein complexes were analysed by gel electrophoresis under nondenaturing conditions. Lanes 1 and 6, no competitor. Lanes 2 and 7, MRE-c' (50 ng) as competitor. Lanes 3 and 8, Sp1 (50 ng) as competitor. Lanes 4 and 9, 50 ng of poly(dI-dC) as competitor. Lanes 5 and 10, 100 ng of poly(dI-dC) as competitor. Arrows indicate speci®c DNA-protein complexes The value was estimated by silver staining.
c Anity column of MRE-c' oligonucleotide coupled to Sepharose in solution as a monomer. In contrast, C'BP-1 exists in solution as a dimer (Aniskovitch and Jacob, 1997).
Third, we carried out Southwestern blotting experiment. This procedure identi®ed two polypeptides with M r 48 and 28 kDa in fraction from CM-Sepharose CL-6B, which exhibited binding anity for MRE-c' (Figure 6a , lane 1). Only one band with M r of 28 kDa was detected when anity-puri®ed C'BP-2 was used in this assay ( Figure 6a , lane 2). The identity of the 48 kDa polypeptide is not known.
Fourth, we used photochemical cross-linking to selectively label C'BP-2 on the basis of its speci®c interaction with MRE-c'. The MRE-c' probe was prepared by incorporating radioactive deoxycytidine into the coding strand. Anity-puri®ed C'BP-2 was incubated with the body-labeled probe under conditions identical to those routinely used in the electrophoretic mobility shift assay. After the binding reaction had reached equilibrium, samples were irradiated with U.V. light and digested with DNase I. The molecular weight of the cross-linked protein was determined by electrophoresis on SDS ± polyacrylamide gel. The extensive nuclease digestion ensured that only short oligonucleotides from the DNA probe remained covalently cross-linked to proteins during electrophoresis. As seen in Figure 6b , only one labeled protein with a molecular mass of 28 000 was visible.
Characterization of C'BP-2 binding to MRE-c'
Examination of the eect of components involved in the binding reaction on MRE-c'/C'BP-2 binding showed that MgCl 2 strongly inhibits the binding activity of C'BP-2 (data not shown). MRE-c'/C'BP-2 binding was reduced twofold as the MgCl 2 concentration was raised from 0 to 2 mM. Titration of the KCl concentration showed a peak for MRE-c'/C'BP-2 binding at 100 mM. Another component, dithiothreitol, was essential for binding. Heat treatment of puri®ed C'BP-2 showed that the DNA-binding activity of C'BP-2 is relatively thermostable; approximately 80, 65 and 37% of the C'BP-2 binding activity survived incubation at 40, 50 and 608C, respectively, for 5 min. Dissociation rate constant (k d ) was also measured for the C'BP-2/MRE-c' complex. We found that k d for the C'BP-2/MRE-c' complex is 5.1 ± 10 73 min 71 (data not shown).
The methylation interference analysis of the C'BP-2/ MRE-c' complex revealed that C'BP-2 made essential contact with the CCAAT-related sequence (7115 to 7110) and in the region upstream of this sequence ( Figure 7a ). Although most of the nucleotide contact sites for C'BP-2 were located within the MRE-c sequence (7135 to 7118) of the mMT-I promoter, the MRE-c oligonucleotide was ineective in competing for C'BP-2 binding (data not shown). These data suggest that the CCAAT-related sequence TGCCAAGG (7117 to 7110) is essential for the interaction with C'BP-2. This conclusion was further supported by the observation that a single-point mutant in which the MRE-c' TGCCAAGG sequence was mutated to TGCAAAGG failed to compete for C'BP-2 binding to MRE-c' (data not shown). In addition, a single-point mutant in which the MRE-c' TGCCAAGG sequence was converted to TGCCTAGG had signi®cantly lower eect upon binding of C'BP-2 to MRE-c' than MRE-c' itself (data not shown).
To delineate the C'BP-2 domains on the mMT-I promoter, we performed DNase I footprinting assay (Figure 8 ). The renatured 28 kDa polypeptide was used for DNase I footprinting presented in Figure 8 . The footprint obtained with native C'BP-2 was identical to that obtained with the renatured 28 kDa polypeptide (data not shown). On the 385-bp EcoRI-BglII fragment containing 7300 to +64 region of the mMT-I gene, two binding sites for C'BP-2 were mapped. The high anity binding site was positioned between nucleotides 7115 and 7145 with respect to the start site of transcription on the coding strand (Figure 8 ). The protected domain partially included the MRE-c' region. The second binding site for C'BP-2 was positioned between nucleotides 7215 to 7185. This binding site was of low anity, as it was mapped on the 385-bp EcoRI-bglII fragment only when the amount of C'BP-2 used for footprinting was increased (data not shown). Anity-puri®ed C'BP-2 can stimulate transcription from the mouse MT-I gene promoter
Identi®cation of the C'BP-2 binding site within the mMT-I promoter suggested that C'BP-2 is a transacting factor of the mMT-I gene. To check the eect of C'BP-2 on transcription from the mMT-I gene promoter, various amounts of anity-puri®ed C'BP-2 were preincubated with a template before adding HeLa nuclear extract. The template (pMTC 2 AT) was a hybrid plasmid containing the mMT-I promoter (7350 to 71) linked to a 394 bp fragment that lacks cytidine residues on the transcribed strand (Datta and Jacob, 1996) . In vitro transcription was carried out in the presence of RNase Tl and the chain terminator 3'-O-methyl-GTP. Under these conditions, the only RNAs that can accumulate are the 394-nucleotide RNase Tl-resistant transcripts resulting from accurate initiation at the mMT-I promoter. As seen in Figure 9 , the amount of the 394-nt RNase Tl -resistant transcript was enhanced by increasing the concentration of C'BP-2. Two-and threefold stimulation of transcription was observed when 0.375 ng (lane 3) and 1.5 ng (lane 2) of C'BP-2, respectively, were used. The absence of the eect of C'BP-2 on transcription of the adenovirus major late promoter which does not contain the C'BP-2 binding sites (data not shown) and a high ratio of the protein amount of HeLa nuclear extract to the protein Figure 4 (a) Renaturation of gel-puri®ed C'BP-2. Anity-puri®ed C'BP-2 was subjected to SDS ± PAGE and proteins from the individual gel slices were eluted, renatured and concentrated as described in Materials and methods. The concentrated protein (10 ml) was assayed for the DNA-binding activity. The protein binding reaction mixture of the load sample (lane 1) included 1 ng of anity-puri®ed C'BP-2. Molecular weights denoted above the gel refer to the location of molecular weight protein standards (Rainbow markers, Amersham) relative to the gel slice boundaries. Protein standards were included in the lane adjacent to the C'BP-2 sample. (b) Comparison of native C'BP-2 and the renatured 28 kDa polypeptide in competition EMSA. Native C'BP-2 (1 ng, lanes 1 ± 5) or the renatured 28 kDa polypeptides (5 ng, lanes 6 ± 10) were preincubated with 10 ng of unlabeled competitor DNAs for 10 min at room temperature before addition of 1 ng of the radiolabeled probe MRE-c'. The reaction mixtures were further incubated at room temperature for 30 min followed by polyacrylamide gel electrophoresis under non-denaturing conditions. Lanes 1 and 6, no competitor. Lanes 2 and 7, MRE-c' as competitor. Lanes 3 and 8, MRE-d as competitor. Lanes 4 and 9, Sp1 as competitor. Lanes 5 and 10, poly (dI-dC) as competitor amount of exogenous C'BP-2 indicate that the activation observed was speci®c and mediated by binding of C'BP-2 to its cognate cis elements containing the CCAAT homology.
Relationship of C'BP-2 to previously described CCAATbinding factors
We have shown previously that C'BP-l could bind to the C/EBP consensus oligonucleotide. Further, the antibody which reacts with all known C/EBP isoforms and the antibody that speci®cally recognizes C/EBPd partially supershifted the C'BP-l/MRE-c' complex. This observation suggests that C'BP-1 is a protein closely related to C/EBPd (Aniskovitch and Jacob, 1997). When the renatured 28 kDa polypeptide and 32 Plabeled C/EBP consensus oligonucleotide as a probe were used in gel shift assay, a speci®c DNA-protein complex was observed (Figure 10a ). The complex of the same mobility was formed when native C'BP-2 was used (data not shown). The DNA-protein complex was not competed out by the Sp1 oligonucleotide whereas the C/EBP consensus oligonucleotide and the MRE-c' inhibited binding of C'BP-2 to the C/EBP consensus oligonucleotide. In two experiments, we used dierent amounts of unlabeled competitor DNAs in the gel binding assay. A 100-fold excess of both C/EBP consensus and MRE-c' oligos abolished binding of C'BP-2 to the C/EBP consensus oligonucleotide. In another experiment using 20-fold excess of the competitors, only a partial inhibition of the binding of C'BP-2 to C/EBP consensus element was observed. Under this condition, maximal inhibition was observed with unlabeled MRE-c' oligo relative to C/EBP consensus oligo. The result of the latter experiment is presented in Figure 10a .
Sedimentation of anity-puri®ed C'BP-2 through a glycerol gradient and monitoring the C/EBP consensus binding activity in EMSA revealed peak of this activity in the same fraction of gradient as the peak of the MRE-c' -binding activity (data not shown). We then tested the antibody reacting with C/EBP isoforms for its ability to in¯uence the mobility shift properties of C'BP-2. The antibody did not supershift the C'BP-2/ MRE-c' complex (Figure 10c ) suggesting that C'BP-2 is not a member of the C/EBP family.
To check whether C'BP-2 is one of the other CCAAT-binding proteins, we used competition electrophoretic mobility shift assay with MLP, g-FBG and NF-I consensus oligonucleotides, to which CP1, CP2 and CTF/NF1, respectively, bind with high anity (Chodosh et al., 1988) . The results from this assay are shown in Figure 10b . Identical results were obtained when the renatured 28 kDa polypeptide was used (data not shown). These data illustrate that only MRE-c' and g-FBG oligonucleotides had eect upon binding of C'BP-2 to MRE-c'. Although, the oligonucleotide g-FBG had a strong eect upon binding of C'BP-2 to 6 8 1 0 Fraction number --- Figure 5 Glycerol gradient sedimentation of C'BP-2. Anity-puri®ed C'BP-2 was sedimented in a 10 to 30% linear glycerol gradient. Gradient fractions (10 ml) were assayed in the standard gel retardation assay with the MRE-c' probe. Only the bound portion of the gel retardation experiment is shown. Molecular weight standards were sedimented in parallel with the C'BP-2 sample, equivalent fractions were collected, and the extent of sedimentation of the standards was determined by analysis of the fractions on a SDS ± polyacrylamide gel. The lower panel shows the plot of S values of the standards with respect to the peak fraction in which they sedimented MRE-c', it did not have eect upon the binding of C'BP-1 to MRE-c' (data not shown). We then compared the interference pattern for C'BP-2/g-FBG with that for CP2/g-FBG (Figure 7b ). The methylation interference pattern of the complex generated by C'BP-2 was similar to that generated by CP2 (Lim et al., 1993) . C'BP-2 contacts with the same guanines as CP2 with exception of guanines at position 4 and 10 in the lower strand. The above data suggest that C'BP-2 is a protein with the DNA binding speci®city closely related to that of CP2.
Discussion
We have identi®ed two elements (one of which is the MRE-c' element) containing CCAAT-homologous sequences within the mouse metallothionein I promoter. Previously we puri®ed and characterized the rat liver protein C'BP-1 which binds to these elements (Aniskovitch and Jacob, 1997). SDS ± PAGE analysis of the C'BP-1 containing fraction from the second DNA anity column revealed that this fraction consists predominantly of two closely migrating bands of *34 kDa. C'BP-1 was shown to bind DNA as a dimer of these polypeptides. We also demonstrated that C'BP-1 is a protein closely related to C/EBPd (Aniskovitch and Jacob, 1997).
Here we report the puri®cation and characterization of a 28 kDa protein from Morris hepatoma 3924A (C'BP-2) with chromatographic behavior distinct from that of C'BP-1. Unlike C'BP-1, C'BP-2 exists in solution as a monomer. DNaseI footprinting revealed two C'BP-2 binding sites in the mMT-I promoter regions that overlap with CCAAT homologies of the C'BP-1 binding sites. C'BP-2 was shown to make critical contacts with the CCAAT homology by methylation interference analysis and competition EMSA with mutants harboring alterations in the CCAAT homology. Although the CCAAT homology was essential for protein-DNA recognition, C'BP-2 showed surprising latitude in nucleotide sequence upstream of the CCAAT homology to which it binds with high anity.
What is the relationship between C'BP-2 and previously described CCAAT-binding factors: CP1, CP2, CTF/NF-1 (Chodosh et al., 1988) and C/EBPs (Williams et al., 1991; Graves et al., 1986) ? The present data showed that C'BP-2 cross-binds to the binding sites of C/EBP and CP2, but not to those of CP1 and CTF/NF-1. Binding of C'BP-2 to the C/EBP consensus oligonucleotide with low anity and failure of the antibodies reacting with all C/EBP isoforms to supershift the C'BP-2/MRE-c' complex suggest that C'BP-2 is not a member of the C/EBP family. Unlike the C/EBP consensus oligonucleotide, g-FBG oligonucleotide had a moderate eect upon binding of C'BP-2 to MRE-c'. Binding of C'BP-2 to the CP2 binding site with high anity coupled with the dierence in the molecular weights of anity-puri®ed C'BP-2 and puri®ed murine CP2 that represent a polypeptide doublet with M r 64 and 66 kDa on SDS ± PAGE (Kim et al., 1988) , suggest that C'BP-2 and CP2 are two closely related, but not identical, DNA binding proteins. This suggestion was further supported by two observations. First, although methylation interference patterns for C'BP-2/g-FBG and CP2/g-FBG are remarkably similar, guanines at position 4 and 10 in the CP2 binding site do not interfere with C'BP-2 complex formation (Figure 7b , lower strand). Second, CP2 is known to bind to the promoters of the murine a-globin, rat g-®brinogen (g-FBG), SV40 late and human immunode®ciency virus (Swendeman, et al., 1994) genes. CP2 was shown to recognize a hyphenated DNA sequence composed of two 4-base motifs separated by a 6-base linker (CNRG-N 6 -CNR(G/c) (Lim et al., 1993) . In three out of four CP2 binding sequences, the CCAAT-related sequence CCA(G/c) represents the right-hand CNRG box. We have noted the elements CTCG-N 6 -CCAA and GCCA-N 6 -CCAA with homology to the CP2 consensus binding sequence within two C'BP-2 binding sequences on the mMT-I promoter. The binding speci®city of C'BP-2 is, therefore, more relaxed in comparison with that of CP2.
Thus, two distinct rat proteins C'BP-1 and C'BP-2 which apparently belong to the dierent subfamily of related transcription factors can recognize CCAAThomologous sequences present at the MT-I promoter. Despite a number of dierences between these proteins, both C'BP-1 and C'BP-2 could stimulate transcription from the mMT-I gene promoter. What is the role for such multiple factors? EMSA that utilized a EDTAcontaining buer system, showed that C'BP-2 had a dominant binding activity for MRE-c' in rat hepatoma cells but not in nonproliferating adult liver cells. On the contrary, the C'BP-1 binding activity was the major activity for MRE-c' in nonproliferating adult liver cells, but not in hepatoma cells. Further, the C'BP-1 binding activity was higher in nuclear extract from the livers of rats bearing Morris hepatoma 3924A than in nuclear extract from normal rat livers; such induction of the C'BP-1 activity is, probably, mediated by IL-6 (Aniskovitch and Jacob, 1997). C'BP-1 and C'BP-2 might, therefore, have qualitatively distinct functions that are necessary at dierent stages of growth of hepatocytes and under dierent physiological conditions.
Materials and methods

Templates and oligonuleotides
The sequences of the oligonucleotides used in this study were as follows: MRE-c that corresponds to 7135 to 7118 bp region of the mMT-I promoter, 5'-CATC-CAAGTGCGCTCGGCTC-3', 3'-GTTCACGCGAGCC-GAGCTAG-5'; MRE-c' that contains the region from 7135 to 7110 bp of the mMT-I promoter, 5'-GATC-GAAAAGTGCGCTCGGCTCTGCCAAGG-3', 3'-CTT TTCACGCGAGCCGAGACGGTTCCCTAG-5'; MRE-c' mutant A (7114), 5'-GATCGAAAAGTGCGCTCGGC TCTGCAAAGG-3', 3'-CTTTTCACGCGAGCCGAGAC GTTTCCCTAG-5'; MRE-c' mutant T (7113) 5'-GATC-GAAAAGTGCGCTCGGCTCTGCCTAGG-3', 3'-CTTT TCACGCGAGCCGAGACGGATCCCTAG-5'; MRE-d corresponding to 7157 to 7135 region of the mMT7I promoter, 5'-GATCCTCTGCACTCCGCCC-3', 3'-GA-GACGTGAGGCGGGCTAG-5'; Sp1 corresponding to 7143 to 7133 bp region of the mMT-I promoter, 5'-ACTCCGCCCGATC-3', 3'-TAGTGAGGCGGGC-5'; C/ EBP consensus oligonucleotide (Santa Cruz Biotechnology), 5'-TGCAGATTGCGCAATCTGCA-3', 3'-ACGTC-TAACGCGTTAGACGT-5'; MLP corresponding to 763 to 783 bp region of the adenovirus major late promoter, 5'-CTACACCTATAAACCAATCAC-3', 3'-GATGTGGA-TATTTGGTTAGTG-5'; g-FBG corresponding to 778 to 758 bp region of the rat g-®brinogene promoter, 5'-TGACCAGTTCCAGCCACTCTT-3', 3'-ACTGGTCAA GGTCGGTGAGAA-5'; NF-I consensus binding sequence, corresponding to +22 to +42 of the left terminus of Ad2 with a point mutation at +28, 5'-TTTTGGCTTGAAGCCAATATG-3', 3'-AAAACCGAAC TTCGGTTATAC-5'.
The following plasmids were used in this study: a minigene of mouse metallothionein-I (pMT-ID i /pMT1) cloned in The labeled oligonucleotide was partially methylated with dimethylsulfate and added to the scaled-up (12-fold) binding reaction containing anity-puri®ed C'BP-2. Bound (B) and free (F) probes were separated by native gel electrophoresis, visualized by autoradiography, eluted, puri®ed, and cleaved with piperidine. Free and bound DNAs (equal radioactivity as determined by scintillation counting) were electrophoresed on 20% polyacrylamide gel under denaturing conditions. The G and A residues involved in contact with C'BP-2 are indicated by solid circles for strongly interfering residues, half-solid circles for modest interfering residues and open circles for weakly interfering residues. The arrow indicate residue at which methylation-enhanced binding was detected. (b) Methylation interference of C'BP-2 binding to the g-FBC oligonucleotide. This data follows discussion of Figure 10 . Methylation interference assay was performed as described above. The G and A residues involved in contact with the protein are indicated by solid circles for strongly interfering residues and open circles for weakly interfering residues pUC18 (a generous gift of Richard Palmiter, Seattle, Washington) which consists of an 897 bp insert containing a 350 bp 5'¯anking sequence and a 547 bp coding sequence; plasmid pMTC 2 AT that was constructed by Prasun Datta (Datta and Jacob, 1996) . This plasmid contains a 377 bp synthetic G-free cassette linked to the MT-I promoter (7350 to +17) in which the G residues at +l and +9 were substituted by C residues and an A residue at position +15 was substituted by a C residue.
Puri®cation of C'BP-2
Morris hepatoma 3924A is a poorly dierentiated, fastgrowing tumor with a mass-doubling time of 4 ± 5 days (Rose et al., 1981) . Nuclear extract from 50 g of this tissue was prepared by the procedure of Kurl and Jacob (1985) .
Solid ammonium sulfate (0.42 g/ml) was added to the nuclear extract in small aliquots. The precipitate was collected by centrifugation in Beckman 50.2 Ti rotor at 32 000 r.p.m. for 1 h at 48C. The pellet was resuspended in buer A (20 mM HEPES-KOH, pH 7.9, 20% glycerol, 0.1 mM EDTA, 2 mM DTT and 0.5 mM PMSF) containing 100 mM KCl and 5 mM MgCl 2 After centrifugation at 39 000 g for 30 min, the soluble protein extract (50 ml) was applied to a DEAE-Sephadex A-25 column (50 ml) equilibrated in the same buer. The C'BP-2 activitȳ owed through the DEAE-Sephadex column. The¯ow-through fraction was applied to a 20 ml heparin-Sepharose CL-6B column equilibrated with buer A containing 100 mM KCI and 5 mM MgC1 2 and eluted by successive addition of buer A (3 column volumes of each) containing 300, 400, 500 and 1 000 mM KCl. Fractions containing the C'BP-2 activity (32 ml), eluted at 500 mM KCl, were pooled, dialyzed against buer A containing 100 mM KCl and applied to a 5-ml CM-Sepharose CL-6B column equilibrated with the same buer. After washing the column with buer A (3 column volumes of each) containing 100 and 200 mM KCl, the C'BP-2 activity was eluted at 400 mM KCI. Fractions containing the C'BP-2 activity were pooled (6 ml total volume), dialyzed against buer B (20 mM HEPES-KOH, pH 7.9, 20% glycerol, 0.1 mM EDTA, 1 mM DTT and 0.1% NP-40) containing 50 mM KCl and applied to a 0.7-ml sequence-speci®c DNA anity column constructed of the double-stranded MRE-c' oligonucleotide as described (Kadonaga and Tjian, 1986) . The column was washed with 10 volumes of buer B containing 50 mM KCl, and the protein was eluted by successive addition of buer B (1.4 ml each) containing 100, 250, 500, 750 and 1 000 mM KCl. Fractions representing the peak of C'BP-2 activity (2.5 ml total volume) were dialyzed against buer B containing 50 mM KCI, mixed with 2 mg of poly(dI-dC), incubated for 10 min on ice and re-chromatographed on the DNA anity column.
Renaturation of the C'BP-2 DNA binding activity
Approximately 2 mg of anity-puri®ed C'BP-2 was subjected to electrophoresis under denaturing conditions as described by Laemmli (1970) . The gel was divided into slices, each slice was crushed and incubated for 4 h at room temperature in 1 ml of elution buer (50 mM Tris-HCl, pH 7.9; 0.1 mM EDTA, 0.1% SDS, 5 mM DTT and 150 mM NaCl). The acrylamide was removed by centrifugation and the eluate was precipitated with 5 vol of acetone at 7208C for 20 min and centrifuged at 13 000 g for 10 min at 48C. The acetone precipitate was resuspended in 1 ml of 50 mM Tris-HCl buer (pH 7.9) with 20% glycerol, 100 mM KCl, 0.1 mM EDTA, 5 mM MgC1 2 , 1 mM DTT, 0.1% NP40 and 6 M guanidine hydrochloride (GnHCl) and incubated for 30 min at room temperature. GnHCl was removed gradually by dialyzing at 48C against 50 mM Tris-HCI (pH 7.9) buer containing 20% glycerol, 100 mM KCI, 0.1 mM EDTA, 5 mM MgC1 2 , 1 mM DTT and 2 M GnHCl followed by dialysis against the same buer without the denaturant. After dialysis, the protein was concentrated 10 times with a Microcon TM 10 (Amicon, Corp.). The DNA binding activity was assayed by electrophoretic mobility shift assay.
Electrophoretic mobility shift assay (EMSA)
The MRE-c' oligonucleotide was labeled with [a- 32 P]dCTP using the Klenow fragment of DNA polymerase I. The binding reaction mixture (20 ml) contained 1 ng of the DNA probe and 1 ± 5 ml of fractions derived from dierent stages of C'BP-2 puri®cation in 20 mM HEPES-KOH (pH 7.9) buer containing 100 mM KCl, 1 mM dithiothreitol, Biotechnology) before addition of the radiolabeled oligonucleotide. Incubation was continued for another 30 min at room temperature. The DNA-protein complexes were resolved by electrophoresis through 6% polyacrylamide gels containing 50 mM Tris, 0.38 M glycine and 2 mM EDTA. To quantitate the gel retardation activity, the radioactivities in the gel slices containing DNA-protein complexes were determined by scintillation counting. One unit of activity is de®ned as the amount of gel retardation activity in 10 mg of the crude nuclear extract. For thermostability studies, anity-puri®ed C'BP-2 (5 ml) was incubated at 30, 40, 50, 60, 70, 80, 90 and 1008C for 5 min. Samples were placed on ice for l0 min and incubated at room temperature for 30 min with 15 ml solution containing l ng of the MRE-c' probe, yielding ®nal concentration of 20 mM HEPES-KOH (pH 7.9), 125 mM KCI, 2 mM DTT, 0.5 mM EDTA, 10% glycerol and 0.025% NP-40.
Dissociation rate constant (k d ) for the C'BP-2/MRE-c' complex was measured by the gel electrophoresis technique of Fried and Crothers (Fried and Crothers, 1981) . Anitypuri®ed C'BP-2 (3-10 712 M) was incubated with 32 P-labeled MRE-c' (3-10 710 M) for 30 min at room temperature in 20 mM HEPES-KOH (pH 7.9) buer containing 50 mM KCl, 1 mM DTT, 0.5 mM EDTA, 10% glycerol and 4 mM MgC1 2 . Dissociation measurements were initiated by addition of a 100-fold molar excess of unlabeled MRE-c'. Samples were taken at intervals and applied immediately to a running gel. Data were plotted according to the ®rst-order rate equation given by Riggs et al. (1970) and k d was calculated by linear regression. The observed rate of dissociation was independent of the amount of unlabeled MRE-c' used as the competitor.
The C/EBP consensus oligonucleotide was labeled with [g-32 P] ATP using polynucleotide kinase. The reaction mixture (20 ml) contained 1 ng of DNA probe and 100 ng of the renatured 28 kDa polypeptide in 10 mM Tris-HCl (pH 7.5) buer with 50 mM NaCl, 1 mM DTT, 1 mM EDTA, 5% glycerol and 0.5 mg/ml BSA. The binding reactions were incubated at room temperature for 30 min and the DNAprotein complexes were resolved as described above.
In competition experiments, the hepatoma nuclear extract, anity-puri®ed C'BP-2 or the renatured 28 kDa polypeptide were preincubated with competitor DNA for 10 min at room temperature prior to addition of the radiolabeled probe.
Southwestern analysis
Southwestern blot analysis was carried out as described previously (Dooley et al., 1992) with slight modi®cation. Nuclear extract (200 mg) of Morris hepatoma 3924A or liver was mixed with 26SDS sample buer and electrophoresis under denaturing conditions as described (Laemmli, 1970) . Proteins were transferred to Immobilon-P membrane (Millipore) by electroblotting at 14 V overnight in buer containing 20 mM Tris, 150 mM glycine and 20% methanol. After blotting, the ®lter was washed for 3 h in buer A (25 mM HEPES-KOH, pH 7.9; 25 mM KCI, 5 mM MgCl 2 , 0.5 mM DTT) at room temperature. The membrane was then blocked with 5% BSA in buer A for 1.5 h, and brie¯y rinsed in buer A containing 0.25% BSA. The ®lter was then incubated in 10 ml of buer A containing 0.25% BSA, 0.03% NP-40 and 2 mg/ml poly (dI-dC) for 30 min at room temperature. After addition of 10 6 c.p.m. (Cerenkov) of 32 Plabeled MRE-c' per ml, incubation was continued for another 5 h at room temperature. The ®lter was washed in buer A containing 0.25% BSA (for changes) over a period 30 min and autoradiographed.
When the C'BP-2 enriched fractions from CM-Sepharose CL-6B and from the second pass on the DNA anity column Eect of C'BP-2 on transcription from the mMT-I gene promoter. Plasmid pMTC 2 AT (200 ng) was preincubated with various amounts of anity-puri®ed C'BP-2 before adding HeLa nuclear extract (18 mg). Lane 1, HeLa nuclear extract plus 1.5 ml of buer B containing 500 mM KCl. Lanes 2 ± 5, Hela nuclear extract plus 1.5, 0.375, 0.1 and 0.025 ng of anity-puri®ed C'BP-2 in buer B containing 500 mM KCl (1.5 ml) respectively. A constant amount of an internal standard was added to check the recovery of nucleic acids were used for Southwestern analysis, they were precipitated with 5 vol of acetone before SDS ± PAGE. The subsequent steps were as described above except that 10 6 c.p.m. (Cerenkov) of 32 P-labeled MRE-c' per ml was added simultaneously with 2 mg poly (dI-dC) in buer containing 0.25% BSA and 0.03% NP-40.
DNaseI footprinting
The 385-bp EcoRI-BglII fragment of pMT-I labeled on the coding strand of the MT-I gene at the internal BgllI site (+64) and released by digestion with EcoRI, which cleaves in the vector, was used for DNaseI footprinting. The endlabeled DNA probe was produced by labeling the indicated restriction enzyme cleavage site with [ 32 P]dGTP and the Klenow fragment. After digestion with the second enzyme, the fragment was puri®ed by polyacrylamide gel electrophoresis. The footprinting assays were performed as described by Landol® et al. (1987) with minor modifications. The reaction mixture (40 ml) contained 0.2 ng of the 3'-end-labeled probe and 1.6 ± 9.6 ng of the renaturated 28 kDa protein in 20 mM HEPES-KOH (pH 7.9) buer containing 100 mM KCl, 1 mM DTT, 0.5 mM EDTA, 10% glycerol, 4 mM MgCl 2 and 0.5 mg/ml BSA. The samples were incubated for 30 min at room temperature. DNaseI treatment was carried out by adding 1 ml of a solution of 50 mM CaC1 2 and 100 mM MgC1 2 to the mixture, followed immediately by addition of 1 ng of DNasel (Worthington). The digestion was allowed to proceed for 1 min at room temperature and stopped by the addition of 6 ml of 200 mM EDTA. Equal amounts (48 ml) of a mixture containing 0.5 M NaCl, 10 mM EDTA (pH 8.0), 0.1% SDS and 0.1 mg of calf thymus DNA per ml were added to the reaction, followed by phenol extraction and ethanol precipitation. DNA samples were resuspended in formamide loading buer, heat-denatured and analysed on 6% polyacrylamide-7 M urea sequencing gel.
Glycerol gradient sedimentation, U.V.-crosslinking and in vitro transcription assay were performed as described previously (Aniskovitch and Jacob, 1997). The methylation interference assay was done as described . Competition electrophoretic mobility shift analysis of C'BP-2 in EMSA using 32 P-labeled MRE-c' as a probe. Anity-puri®ed C'BP-2 (2.5 ng) was preincubated with 10 ng (lanes 2, 4, 6, 8) or 30 ng (lanes 3, 5, 7, 9) of unlabeled competitor DNAs for 10 min at room temperature before addition of 1 ng of the radiolabeled MRE-c' oligonucleotide. The reaction mixtures were further incubated at room temperature for 30 min. The binding reactions were analysed by native gel electrophoresis. Lane 1, no competitor. Lanes 2 and 3, MRE-c' oligonucleotide as competitor. Lanes 4 and 5, Sp1 as competitor. Lanes 6 and 7, NF-I consensus oligonucleotide as competitor. Lanes 8 and 9, MLP oligonucleotide as competitor. Lanes 10 and 11, g-FBC oligonucleotide as competitor. Only the bound portion of the gel retardation experiment is shown. (c) Eect of antibodies against C/EBP isoforms on the electrophoretic mobility shift of C'BP-1 and C'BP-2. Anity-puri®ed C'BP-2 (lanes 1 and 2) or C'BP-1 (lanes 3 and 4) was preincubated for 1 h at room temperature with the antibody (2 ml) before addition of the radiolabeled MRE-c' oligonucleotide. Incubation was continued for another 30 min at room temperature. The binding reactions were analysed by gel electrophoresis under nondenaturing condition. Lanes 1 and 3, Ig that speci®cally recognizes C/EBPb; lanes 2 and 4, Ig that reacts with all C/EBP isoforms 
